Compare ICICI Bank Limited Common Stock (IBN) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ICICI Bank Limited Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? ICICI Bank Limited Common Stock trades at $27.89 (market cap $100.09B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: ICICI Bank Limited Common Stock is far larger — about 44.1× SELLAS Life Sciences Group Inc. Common Stock's market cap, and ICICI Bank Limited Common Stock pays a 0.9% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IBN | SLS | |
|---|---|---|
Market Cap | $100.09B | $2.27B |
Volume | 5,088,983 | 4,179,659 |
Sector | Financials | Health |
52-Week High | $32.94 | $15.46 |
52-Week Low | $25.20 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $10.03T | $2.14B |
Dividend Yield | 0.9% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ICICI Bank Limited Common Stock
ICICI Bank is an Indian financial services company providing banking, lending, cards, insurance, and investment products. It serves retail, business, and corporate customers.
Read more on IBN →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
